Nicholas S. Green
2023
In 2023, Nicholas S. Green earned a total compensation of $6.5M as President and Chief Executive Officer at Peregrine Pharmaceuticals, a 5% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $662,000 |
|---|---|
| Salary | $642,308 |
| Stock Awards | $5,112,128 |
| Other | $45,348 |
| Total | $6,461,784 |
Green received $5.1M in stock awards, accounting for 79% of the total pay in 2023.
Green also received $662K in non-equity incentive plan, $642.3K in salary and $45.3K in other compensation.
Rankings
In 2023, Nicholas S. Green's compensation ranked 28th out of 1,352 executives tracked by ExecPay. In other words, Green earned more than 97.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 28 out of 1,352 | 98th |
Division Manufacturing | 16 out of 666 | 98th |
Major group Chemicals And Allied Products | 9 out of 320 | 97th |
Industry group Drugs | 9 out of 296 | 97th |
Industry Pharmaceutical Preparations | 6 out of 223 | 97th |
Pay ratio
| Nicholas S. Green's Pay | $6,461,784 |
|---|---|
| Median Employee's Pay | $104,595 |
| Pay Ratio | 62to 1 |
In 2023, the annual total compensation of Nicholas S. Green was $6,461,784.
The annual total compensation of the median employee at Peregrine Pharmaceuticals was $104,595.
The ratio of Nicholas S. Green's pay to the pay of median employee was therefore 62 to one.
Source: SEC filing on August 28, 2023.
Green's colleagues
We found four more compensation records of executives who worked with Nicholas S. Green at Peregrine Pharmaceuticals in 2023.